Indaptus Non Current Liabilities Total vs Net Debt Analysis

INDP Stock

USD 1.18 0.03 2.61%

Indaptus Therapeutics financial indicator trend analysis is infinitely more than just investigating Indaptus Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Indaptus Therapeutics is a good investment. Please check the relationship between Indaptus Therapeutics Non Current Liabilities Total and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Non Current Liabilities Total vs Net Debt

Non Current Liabilities Total vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Indaptus Therapeutics Non Current Liabilities Total account and Net Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Indaptus Therapeutics' Non Current Liabilities Total and Net Debt is 0.5. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Net Debt in the same time period over historical financial statements of Indaptus Therapeutics, assuming nothing else is changed. The correlation between historical values of Indaptus Therapeutics' Non Current Liabilities Total and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Indaptus Therapeutics are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Current Liabilities Total i.e., Indaptus Therapeutics' Non Current Liabilities Total and Net Debt go up and down completely randomly.

Correlation Coefficient

0.5

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Non Current Liabilities Total

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Indaptus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.As of 11/14/2024, Selling General Administrative is likely to drop to about 5.3 M. Issuance Of Capital Stock is expected to grow at the current pace this year

	2021	2022	2023	2024 (projected)
Interest Expense	17.7K	588.1K	676.3K	710.1K
Depreciation And Amortization	1.4K	1.8K	1.3K	1.2K

Interest Expense Depreciation And Amortization

Indaptus Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment
Total Assets		-0.04	-0.02	0.17	0.92	0.56	-0.02	-0.78	0.02	0.37	0.8	-0.02	-0.03	-0.41	0.85	-0.03	0.24	0.24	0.08	0.68	0.07	0.13	0.92	-0.03	0.01	0.6
Short Long Term Debt Total	-0.04		1.0	0.98	-0.42	-0.77	1.0	0.43	-0.99	0.91	-0.39	1.0	0.99	0.86	-0.55	1.0	-0.81	-0.35	0.81	-0.74	0.99	0.98	-0.42	1.0	1.0	-0.77
Other Current Liab	-0.02	1.0		0.98	-0.4	-0.77	1.0	0.44	-0.99	0.91	-0.4	1.0	0.99	0.86	-0.54	1.0	-0.79	-0.28	0.85	-0.73	0.99	0.99	-0.41	1.0	1.0	-0.77
Total Current Liabilities	0.17	0.98	0.98		-0.22	-0.65	0.98	0.27	-0.97	0.98	-0.22	0.98	0.97	0.78	-0.37	0.98	-0.75	-0.27	0.83	-0.59	0.99	1.0	-0.22	0.98	0.99	-0.64
Total Stockholder Equity	0.92	-0.42	-0.4	-0.22		0.81	-0.4	-0.88	0.4	-0.01	0.88	-0.4	-0.41	-0.7	0.99	-0.41	0.53	0.36	-0.23	0.91	-0.31	-0.26	1.0	-0.41	-0.37	0.84
Net Tangible Assets	0.56	-0.77	-0.77	-0.65	0.81		-0.76	-0.79	0.74	-0.49	0.77	-0.75	-0.74	-0.95	0.87	-0.77	0.87	0.32	-0.61	0.97	-0.68	-0.67	0.81	-0.77	-0.74	0.98
Property Plant And Equipment Net	-0.02	1.0	1.0	0.98	-0.4	-0.76		0.42	-0.99	0.92	-0.38	1.0	0.99	0.86	-0.54	1.0	-0.79	-0.31	0.84	-0.73	0.99	0.99	-0.4	1.0	1.0	-0.76
Net Debt	-0.78	0.43	0.44	0.27	-0.88	-0.79	0.42		-0.45	0.06	-1.0	0.45	0.47	0.63	-0.89	0.44	-0.39	0.07	0.5	-0.87	0.37	0.3	-0.89	0.44	0.41	-0.88
Retained Earnings	0.02	-0.99	-0.99	-0.97	0.4	0.74	-0.99	-0.45		-0.91	0.4	-1.0	-1.0	-0.82	0.54	-0.99	0.74	0.3	-0.83	0.72	-1.0	-0.98	0.41	-1.0	-0.99	0.76
Accounts Payable	0.37	0.91	0.91	0.98	-0.01	-0.49	0.92	0.06	-0.91		-0.01	0.91	0.9	0.65	-0.16	0.91	-0.68	-0.25	0.77	-0.41	0.94	0.97	-0.01	0.91	0.93	-0.47
Cash	0.8	-0.39	-0.4	-0.22	0.88	0.77	-0.38	-1.0	0.4	-0.01		-0.41	-0.43	-0.61	0.88	-0.4	0.36	-0.1	-0.48	0.85	-0.33	-0.25	0.89	-0.39	-0.37	0.85
Non Current Assets Total	-0.02	1.0	1.0	0.98	-0.4	-0.75	1.0	0.45	-1.0	0.91	-0.41		1.0	0.83	-0.54	1.0	-0.76	-0.29	0.84	-0.73	0.99	0.98	-0.41	1.0	1.0	-0.77
Non Currrent Assets Other	-0.03	0.99	0.99	0.97	-0.41	-0.74	0.99	0.47	-1.0	0.9	-0.43	1.0		0.82	-0.55	0.99	-0.73	-0.25	0.86	-0.73	0.99	0.98	-0.41	0.99	0.99	-0.77
Other Assets	-0.41	0.86	0.86	0.78	-0.7	-0.95	0.86	0.63	-0.82	0.65	-0.61	0.83	0.82		-0.78	0.87	-0.93	-0.38	0.67	-0.91	0.78	0.79	-0.7	0.86	0.84	-0.91
Cash And Short Term Investments	0.85	-0.55	-0.54	-0.37	0.99	0.87	-0.54	-0.89	0.54	-0.16	0.88	-0.54	-0.55	-0.78		-0.55	0.61	0.37	-0.36	0.96	-0.46	-0.4	0.99	-0.55	-0.52	0.91
Net Receivables	-0.03	1.0	1.0	0.98	-0.41	-0.77	1.0	0.44	-0.99	0.91	-0.4	1.0	0.99	0.87	-0.55		-0.8	-0.3	0.84	-0.74	0.99	0.99	-0.41	1.0	1.0	-0.77
Common Stock Shares Outstanding	0.24	-0.81	-0.79	-0.75	0.53	0.87	-0.79	-0.39	0.74	-0.68	0.36	-0.76	-0.73	-0.93	0.61	-0.8		0.54	-0.51	0.77	-0.72	-0.76	0.52	-0.8	-0.78	0.77
Short Term Investments	0.24	-0.35	-0.28	-0.27	0.36	0.32	-0.31	0.07	0.3	-0.25	-0.1	-0.29	-0.25	-0.38	0.37	-0.3	0.54		0.26	0.33	-0.27	-0.29	0.34	-0.33	-0.28	0.22
Non Current Liabilities Total	0.08	0.81	0.85	0.83	-0.23	-0.61	0.84	0.5	-0.83	0.77	-0.48	0.84	0.86	0.67	-0.36	0.84	-0.51	0.26		-0.57	0.84	0.83	-0.25	0.82	0.85	-0.67
Other Current Assets	0.68	-0.74	-0.73	-0.59	0.91	0.97	-0.73	-0.87	0.72	-0.41	0.85	-0.73	-0.73	-0.91	0.96	-0.74	0.77	0.33	-0.57		-0.65	-0.62	0.91	-0.74	-0.71	0.99
Other Stockholder Equity	0.07	0.99	0.99	0.99	-0.31	-0.68	0.99	0.37	-1.0	0.94	-0.33	0.99	0.99	0.78	-0.46	0.99	-0.72	-0.27	0.84	-0.65		0.99	-0.32	0.99	0.99	-0.7
Total Liab	0.13	0.98	0.99	1.0	-0.26	-0.67	0.99	0.3	-0.98	0.97	-0.25	0.98	0.98	0.79	-0.4	0.99	-0.76	-0.29	0.83	-0.62	0.99		-0.26	0.99	0.99	-0.67
Total Current Assets	0.92	-0.42	-0.41	-0.22	1.0	0.81	-0.4	-0.89	0.41	-0.01	0.89	-0.41	-0.41	-0.7	0.99	-0.41	0.52	0.34	-0.25	0.91	-0.32	-0.26		-0.42	-0.38	0.85
Short Term Debt	-0.03	1.0	1.0	0.98	-0.41	-0.77	1.0	0.44	-1.0	0.91	-0.39	1.0	0.99	0.86	-0.55	1.0	-0.8	-0.33	0.82	-0.74	0.99	0.99	-0.42		1.0	-0.78
Common Stock	0.01	1.0	1.0	0.99	-0.37	-0.74	1.0	0.41	-0.99	0.93	-0.37	1.0	0.99	0.84	-0.52	1.0	-0.78	-0.28	0.85	-0.71	0.99	0.99	-0.38	1.0		-0.75
Property Plant Equipment	0.6	-0.77	-0.77	-0.64	0.84	0.98	-0.76	-0.88	0.76	-0.47	0.85	-0.77	-0.77	-0.91	0.91	-0.77	0.77	0.22	-0.67	0.99	-0.7	-0.67	0.85	-0.78	-0.75

Click cells to compare fundamentals

Indaptus Therapeutics Account Relationship Matchups

Pair Trading with Indaptus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Indaptus Stock

0.71

VALN

Valneva SE ADR

Pair Corr

Moving against Indaptus Stock

0.62	VERA	Vera Therapeutics	Pair Corr
0.57	DMAC	DiaMedica Therapeutics	Pair Corr
0.55	DNLI	Denali Therapeutics	Pair Corr
0.51	VCYT	Veracyte	Pair Corr

The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.

The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC